Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Samaniego
Characteristics and Management of Rash Following Lenalidomide and Rituximab in Patients With Untreated Indolent Non-Hodgkin Lymphoma
Haematologica
Hematology
HuR Suppresses Fas Expression and Correlates With Patient Outcome in Liver Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Prognostic Value of Pre-Treatment Pet Scan in Patients With Follicular Lymphoma Receiving Frontline Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Immunologic Doublet of Lenalidomide Plus Obinutuzumab Is Highly Active in Relapsed/Refractory Follicular Lymphoma, Results of a Phase I/Ii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Treatment With Combination of Lenalidomide and Rituximab Achieves Durable Responses in a Long Term Follow Up of Patients With Indolent Non-Hodgkin's Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PRELIMINARY RESULTS OF ASTX660, a NOVEL NON-PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-Cell LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cloning of the cDNA Encoding an RNA Regulatory Protein--The Human Iron-Responsive Element-Binding Protein.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
